In the realm of biological research, particularly when working with transgenic models, precise tools are essential. My experience with the OT-II peptide has highlighted its role as a fundamental component for studying T-cell biology. Whether you are mappi 17 May 2014—I am trying to activate CD4+ or CD8+ using EG7-OVA cell line in vitro. I have only been successful with activating them using the EG7 vs CD8s.Read more ng epitopes or investigating T-cell activation pathways, understanding the specificity and structural requirements of this peptide is crucial for consistent results.
The Nature of the OT-II Peptide
The OT-II peptide, often referred to by its sequence H-ISQAVHAAHAEINEAGR-OH, is derived from chicken ovalbumin. It is specifically recognized by the T-cell receptor (TCR) found in OT-II transgenic mice. These transgenic mice express the mouse alpha-chain and beta-chain T cell receptor that pairs with the CD4 co-receptor, making them an invaluable model for tracking CD4+ T-cell responses.
From a structural standpoint, the peptide is defined as OVA peptide 323-339. While some OVA peptide 323-339represents a T and B cell epitope of OVA, which is important in the generation and development of immediate hypersensitivity responses Read more protocols utilize the full sequence, others look at shorter variations, such as OVA (ovalbumin) peptide residues 257 to 280, though the 323-339 fragment is the standard for most OT-II related assays. Researchers often note that the OVA (329-339) induces to reach the half-maximal proliferation in specific cell cultures, demonstrating the sensitivity of the system to sequence length.
Key Characteristics and Experimental Utility
When working with these peptides, I have found The OT-II model reveals dual in vitro and in vivo that consiste A Researcher's Guide to Control Peptides for OVA-T4 ncy in preparation is key. The OVA wt peptide 323-339 is frequently used because it is both specific for a C-terminal epitope that resides within the ovalbumin protein. This makes it a highly reliable tool for:
* Mapping T-cell Epitopes: OVA-II is a widely used tool for mapping T cell epitopes, allowing by JM Robertson·2000·Cited by 476—The OVA323–339 epitope recognized by DO11.10 (H-2d) andOT-II(H-2b) T cells was investigated using amino- and carboxy- terminal truncations to locate the Read more for the clear identification of activation triggers.
* Monitoring Responses: The use of specialized reagents, such as the I-Ab OVA 323-339 Tetramer, can be used to monitor antigen-specific CD4 T cell responses in OT-II mice with high precision.
* Inhibitory Studies: Some studies have show 17 May 2014—I am trying to activate CD4+ or CD8+ using EG7-OVA cell line in vitro. I have only been successful with activating them using the EG7 vs CD8s.Read more n that specific compounds, such as OvALT-2 suppresses OVA-specific OT-II T cell proliferation in controlled *in vitro* environments, which is useful for baseline validation.
Insights from the OT-II Model
The OT and II designations are central to this research model. Because the mouse expresses a T cell receptor (TCR) specific for the OVA323-339 peptide, it serves as a "gold standard" for observing how cells interact with specific antigens.
In my own observations, the Ovalbumin protein Ova (323-339) is not just a sequence; it is a gateway to understanding the mechanics of MHC class II presentation. While the peptide itself is chemically defined—with a molecular weight of 1,773.9 g/mol—its biological behavior is dependent on the purity and the specific experimental context. Whether you are conducting OT II studies in a lab or verifying the OT II Peptide H-ISQAVHAAHAEINEAGR-OH against control samples, the precision of your reagents will dictate the quality of your data.
Final Thoughts on Best Practices
For those new to this area, remember that by A Leyton-Pereira·2025—TheOT-IImodel reveals dual in vitro and in vivo immunomodulatory properties of CD6 in T cell activation.Read more the OT-II model is highly sensitive. Ensuring that your peptide is stored correctly and handled according to the manufacturer’s protocols is essential for preventing degradation. Always verify the sequence purity, as even minor variations can alter the activation thresholds of the T-cells. By focusing on these technical details, you can ensure that your experiments remain robust, reproducible, and aligned with current standards in the field.